Toxicology News and Research

Latest Toxicology News and Research

LAB Research announces preferred provider agreement with leading Japanese pharmaceutical company

LAB Research Inc., a Canadian-based global non-clinical contract research organization, today announced that it has entered into a preferred provider agreement with a leading Japanese pharmaceutical company.

27 Jul 2010

AACP, FDA and HRSA partner to introduce study that positively impacts patient health

The American Association of Colleges of Pharmacy, in partnership with the U.S. Food and Drug Administration and the Office of Pharmacy Affairs in the Health Resources and Services Administration, has completed a baseline evaluation of the integration of the "Science of Safety" into the curriculum of the Doctor of Pharmacy degree at accredited colleges and schools of pharmacy.

27 Jul 2010

QRxPharma reports positive outcome of European Scientific Advice meetings on MoxDuo IR pain therapy

QRxPharmareported today positive outcomes of its European Scientific Advice meetings on the development and registration of MoxDuo IR, an immediate release Dual-Opioid™ pain therapy. The Company is currently completing pivotal Phase 3 trials required for filing a New Drug Application (NDA) for MoxDuo IR with the United States Food and Drug Administration (FDA).

26 Jul 2010

Protein parkin essential for hypothalamic neurons recovery in Parkinson's disease patients

A Michigan State University researcher is working to uncover how a protein known as parkin may help nerve cells fight off damage from Parkinson's disease, a strategy that could lead to new therapies for the degenerative ailment.

23 Jul 2010

Five new large pharma clients place initial studies with LAB Research

LAB Research Inc., a Canadian-based global non-clinical contract research organization, today announced that five new large pharma clients have placed initial studies with the Company following the successful pre-qualification of its sites. These new clients are expected to represent at least 5-10% of the Company's revenues by 2011.

21 Jul 2010

University of Luebeck becomes part of Metaminer Cardiac Partnership

GeneGo, Inc., a leading provider of databases, software and services in systems biology and chemistry, announced today that Dr. Salah Mohamed in Department of Cardio and Thoracic Vascular Surgery at the University of Luebeck and his team will be part of the Metaminer Cardiac Partnership. Dr. Mohamed is published within 6 different reputed Scientific American Journals in connection with Biomarker Discovery work performed for the American Heart Association.

21 Jul 2010

FDA joins Tox21 collaboration for improved chemical screening

The U.S. Environmental Protection Agency (EPA), the National Institute of Environmental Health Sciences National Toxicology Program (NTP) and the National Institute of Health Chemical Genomics Center (NCGC) welcome the U.S. Food and Drug Administration (FDA) to the Tox21 collaboration. The Tox21 collaboration merges federal agency resources (research, funding and testing tools) to develop ways to more effectively predict how chemicals will affect human health and the environment. The collaboration was established in 2008 to develop models that will be able to better predict how chemicals will affect humans. FDA will provide additional expertise and chemical safety information to improve current chemical testing methods.

20 Jul 2010

Bionas launches new Bionas adcon reader for impedance-based, cellular analysis

Bionas GmbH announces the launch of its new Bionas® adcon reader for impedance-based, cellular analysis. The Bionas adcon reader technology is based on real-time monitoring of cellular impedance, thus giving real-time data about cell adhesion, membrane integrity, cellular morphology and cell proliferation for applications in toxicology, oncology, receptor signaling as well as the quality management of cells.

19 Jul 2010

JANA Partners sends detailed critique of Charles River's revised investor presentation on WuXi acquisition

JANA Partners LLC today sent Charles River Laboratories International, Inc. a detailed critique of Charles River's revised investor presentation released earlier this week, in which Charles River once again seeks to persuade shareholders of the merits of its proposed acquisition of WuXi PharmaTech (Cayman) Inc..

17 Jul 2010

Long-term exposure of arsenic may increase risk for lung cancer

To determine how arsenic increases the risk of lung cancer and to identify potential treatments, a Michigan State University researcher will use $1.7 million in federal funding during the next five years to examine why certain genes disrupt cells, leading to the disease.

15 Jul 2010

Variations in quality of illegal Class B drug mephedrone could risk safety of users

Pharmaceutical scientists have discovered that the recently reclassified drug mephedrone varies in quality so much that users could be at risk of overdosing. Six samples were tested in the University of Sunderland's labs by Dr John Lough and his team, and although impurities levels were low, three samples revealed various particle size and crystalline form, which means that the drug is more likely to vary in its affect and safety on the user.

15 Jul 2010

Maven Semantic announces updates to database of Toxicology researchers

Maven Semantic announces updates to their Toxicology database.

14 Jul 2010

Research provides understanding of EGME's effects on metabolism

Metabolon, Inc., the leader in global metabolism, biomarker discovery and analysis, announces the publication of "Ethylene Glycol Monomethyl Ether-Induced Toxicity is Mediated through the Inhibition of Flavoprotein Dehydrogenase Enzyme Family", in the journal Toxicological Sciences on July 8, 2010. The paper was co-authored by Dr. Makoto Takei and colleagues at Daiichi-Sankyo in collaboration with Metabolon scientists.

14 Jul 2010

Affygility Solutions releases new version of Affytrac EH&S software with multi-corrective action functionality

Affygility Solutions, LLC, a global leader in providing environmental, health and safety solutions to the life sciences industry, announced today the launch of its newest version of its environmental, health, and safety software, Affytrac, with multi-corrective action functionality. Users can now create an infinite amount of corrective actions for a single parent issue.

13 Jul 2010

GVK BIO receives AAALAC certification for animal facilities

GVK Biosciences Private Limited , Asia's leading Contract Research Organization, today announced that it received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC) International for its animal facilities.

12 Jul 2010

Data shows potential health benefits of S-equol in relieving menopausal symptoms

The findings of a scientific conference examining the growing body of research and potential health benefits of S-equol were published this month in the Journal of Nutrition. Manuscripts based on presentations made at the conference, which was organized by the Life Sciences Research Office, reveal data that S-equol is a safe, natural and effective solution to providing relief of menopausal symptoms such as hot flashes and muscle discomfort.

9 Jul 2010

Advanced Life Sciences announces positive results from preclinical studies of Restanza IV

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced positive results from preclinical toxicology and pharmacokinetic studies of an intravenous (IV) formulation of its novel antibiotic, Restanza™ that support its use in a hospital setting.

8 Jul 2010

Study finds additional targets for new therapies to treat advanced prostate cancer patients

In its early stages, prostate cancer requires androgens (hormones that promote the development and maintenance of male sex characteristics) for growth, and current first-line therapies target the receptor for these hormones to slow cancer's development and spread.

7 Jul 2010

Metabolon unveils novel approach to identify patients at preterm delivery risk

Metabolon, Inc., the leader in global metabolism, biomarker discovery and analysis, announces the publication of "Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery", in The Journal of Maternal-Fetal and Neonatal Medicine.

3 Jul 2010

Advanced Cancer Therapeutics secures $10M in investments

Advanced Cancer Therapeutics (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that it has secured $10 million in investments from high net-worth individuals and institutions. This round of investment, which closed six months ahead of the company's year-end goal, will provide ACT additional capital to continue its development and commercialization of potentially lifesaving therapeutics for cancer patients.

2 Jul 2010

Toxicology News and Research

Latest Toxicology News and Research

LAB Research announces preferred provider agreement with leading Japanese pharmaceutical company

AACP, FDA and HRSA partner to introduce study that positively impacts patient health

QRxPharma reports positive outcome of European Scientific Advice meetings on MoxDuo IR pain therapy

Protein parkin essential for hypothalamic neurons recovery in Parkinson's disease patients

Five new large pharma clients place initial studies with LAB Research

University of Luebeck becomes part of Metaminer Cardiac Partnership

FDA joins Tox21 collaboration for improved chemical screening

Bionas launches new Bionas adcon reader for impedance-based, cellular analysis

JANA Partners sends detailed critique of Charles River's revised investor presentation on WuXi acquisition

Long-term exposure of arsenic may increase risk for lung cancer

Variations in quality of illegal Class B drug mephedrone could risk safety of users

Maven Semantic announces updates to database of Toxicology researchers

Research provides understanding of EGME's effects on metabolism

Affygility Solutions releases new version of Affytrac EH&S software with multi-corrective action functionality

GVK BIO receives AAALAC certification for animal facilities

Data shows potential health benefits of S-equol in relieving menopausal symptoms

Advanced Life Sciences announces positive results from preclinical studies of Restanza IV

Study finds additional targets for new therapies to treat advanced prostate cancer patients

Metabolon unveils novel approach to identify patients at preterm delivery risk

Advanced Cancer Therapeutics secures $10M in investments

Forensics and toxicology - Industry Focus eBook eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Toxicology News and Research

Latest Toxicology News and Research

Forensics and toxicology - Industry Focus eBook eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in